GF
DNA icon

Gabelli Funds’s Ginkgo Bioworks DNA Stock Holding History

Gabelli Funds’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-405
Closed -$50K – 1223
2022
Q3 		$50K Hold
405
– – ﹤0.01% 1221
2022
Q2 		$39K Sell
405
-1,875
-82% -$229K ﹤0.01% 1260
2022
Q1 		$367K Sell
2,280
-1,470
-39% -$286K ﹤0.01% 1119
2021
Q4 		$1.25M Buy
+3,750
New +$1.78M 0.01% 842

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Gabelli Funds's DNA Position: Q4 2022 in Review

Gabelli Funds sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 405 shares — an estimated $50K sold.

Gabelli Funds first reported a position in DNA in Q4 2021 and held it in 4 quarters. The position peaked at $1.25M in Q4 2021. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Gabelli Funds reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 405 Ginkgo Bioworks shares in Q4 2022, an estimated $50K.
  • Gabelli Funds first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 4 quarters.
  • Gabelli Funds's Ginkgo Bioworks position peaked at $1.25M in Q4 2021.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.